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Although lower extremity edema/lymphedema can result from venous or lymphatic abnormalities, effective treatment
depends on understanding their relative contributions to the condition. Herein we use near-infrared ﬂuorescence
lymphatic imaging in a 16-year-old girl diagnosed with unilateral lymphedema of the right leg and previously treated with
left iliac vein stenting in an attempt to alleviate lymphedema. The imaging shows that abnormal lymphatic anatomy,
rather than venous occlusion, was likely responsible for unilateral swelling. (J Vasc Surg Cases 2015;1:201-4.)The venous and lymphatic systems are intimately linked
through embryologic development and causation of edema.
In patients with lower extremity edema, both systems may
be dysfunctional. Yet, whereas venous abnormalities are
often clinically obvious, lymphatic dysfunction is not
routinely assessed. Lymphatic dysfunction has been demon-
strated with bipedal lymphography in patients with Klippel-
Trénaunay syndrome1 and with lymphoscintigraphy in
patients with May-Thurner syndrome,2 suggesting a poten-
tial dual venous and lymphatic etiology for edema.
Understanding the underlying cause of edema is key to
management. Although imaging is commonly employed to
diagnose venous disease, lymphatic imaging is used less
frequently. We present the case of an adolescent girl who
underwent stenting of a left iliac stenosis for the indication
of reducing lymphedema in the right leg. On referral to us
for persistent edema, we used investigational near-infrared
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CASE REPORT
The subject was diagnosed at the age of 12 years with unilateral
lymphedema praecox of the right leg. Phlebography revealed a 90%
stenosis of the contralateral (left) iliac vein and abundant venous col-
laterals across the pelvis to the right iliac system (Fig 1,A). Therewas
no previous hematoma or other causative event associated with her
lymphedema. According to her records from another institution, it
was hypothesized that the additional venous load produced by the
collateral veins reduced the venous outﬂow on the right side, which
contributed to her lymphedema. At the age of 14 years, her treating
physician successfully stented the left iliac vein (Fig 1,B), but no clin-
ical improvementwas noted in her edematous right leg. At the age of
16 years, the subject presented to our clinic for lymphatic imaging as
part of a Food andDrug Administration- (IND 102,827) and Insti-
tutional Review Board-approved investigational study for off-label
use of indocyanine green (ICG) using NIRFLI (NCT00833599;
www.clinicaltrials.gov). At presentation, the subject was 5.5 feet
tall with a body mass index of 20.7 and a 34% increase in volume
of the right leg over the left (Fig 2, A and B).
After informed consent of the subject and her guardian, 12 in-
jections, each containing 25 mg of ICG in 0.1 mL of saline, were
intradermally administered, as shown in Fig 2, C, for uptake into
the lymphatic plexus for mapping of reported lymphatic drainage
pathways.3 NIRFLI was accomplished by illuminating the legs
with diffuse 785-nm light and collecting the resultant 830-nm
ﬂuorescent signal emanating from ICG-laden lymph with a
customized camera using night vision technology (for review of
NIRFLI and ICG lymphography, see reference 4). Images were
evaluated for abnormal dermal backﬂow (in which lymphatic ves-
sels drain distally into the lymphatic capillaries), tortuous lymphatic
vessels, and lymphatic contractile dysfunction.5,6
Distinct differences in lymphatic anatomy and contractile
function were observed between left and right legs, as illustrated
in Fig 3 and in Supplementary Videos 1 and 2. Whereas tortuous
lymphatic vessels and extensive dermal backﬂow were observed in
the lymphedematous (right) leg, the lymphatics in the asymptom-
atic (left) leg were linear and well deﬁned, as typically seen in con-
trol subjects. Regular lymphatic contractile propulsion events,201
Fig 1. Venograms of the left iliac occlusion and collateral veins before (A) and after (B) stent placement. Images
obtained from the subject’s medical record.
Fig 2. Images of the upper (A) and lower (B) legs of the subject. (C) Location of the injection sites. Injection sites
were covered with sterile bandages and, when the ﬂuorescent signal oversaturated the camera, black vinyl tape.
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toward the inguinal region in the asymptomatic leg
(Supplementary Video 1). For each contractile event, the apparent
velocity of a “packet” of ICG-laden lymph was computed alongwith the period of time between successive contractile events.5
In the subject’s asymptomatic leg, 61 contractile events were
observed with an average propulsion velocity of 0.8 6 0.2 cm/s
and an average period of 76 6 37 seconds. Whereas diffuse
Fig 3. Montage of near-infrared ﬂuorescence lymphatic images
illustrating the lymphatics in the right lymphedematous (A) and
left asymptomatic (B) legs. The inset in (A) shows the tortuous
lymphatics in the lateral ankle. Injection sites are covered by round
bandages or black vinyl tape.
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right leg, only four contractile events, with an average propulsion
velocity of 0.4 6 0.1 cm/s and an average period of 57 6 7 sec-
onds, were observed in the vessel on the lateral ankle (Fig 3, A,
inset, and Supplementary Video 2). Previously, we found the
average velocity to be 0.96 0.7 cm/s with a period of 526 36 sec-
onds in the legs of control subjects and 0.8 6 0.4 cm/s and 72 6
45 seconds and 0.86 0.5 cm/s and 65.3 6 46.4 seconds in symp-
tomatic and asymptomatic legs of persons diagnosed with lymphe-
dema, respectively.8 Thus, whereas the asymptomatic left leg
possessed normal lymphatic anatomy, the period is similar to
that seen in the symptomatic and asymptomatic legs of lymphe-
dema patients. The average propulsion velocity in the symptomatic
leg was half that observed previously, although the period was
comparable to that of normal legs. No lymphatic pathways were
observed traversing the pelvis between the left and right inguinal
regions as previously observed in a subject with Parkes-Weber syn-
drome.9 To summarize, the lymphatic anatomy and function of
this subject’s lymphedematous right leg and asymptomatic left
leg are consistent with those observed in the lymphedematous
and asymptomatic legs of subjects with lymphedema.
DISCUSSION
Most clinicians rely on both history and physical exam-
ination to diagnose lymphedema: for secondary lymphe-
dema, a history of extirpative surgery or radiation therapyfor neoplasm, major trauma, or recurrent cellulitis; whereas
for primary lymphedema, female gender and left lower ex-
tremity edema beginning at menarche are suggestive of the
diagnosis. Elephantine limb enlargement, dorsal “buffalo
hump” over the metatarsals, and presence of Stemmer
sign are associated with a lymphatic etiology. Although
duplex ultrasound imaging is used routinely to deﬁne anat-
omy and venous function to objectively diagnose venous
disease, there is no standard diagnostic for lymphedema.
Lymphography, a surgical procedure requiring cannulation
of a lymphatic vessel, provides only anatomic, but not func-
tional, information. Lymphoscintigraphy, requiring intra-
dermal or subcutaneous injection of a radionuclide, is
based on the proximal movement of the tracer by
lymphatic pumping function. Although it was not per-
formed in this case, lymphoscintigraphy has been advo-
cated as a method for the differential diagnosis of edema
and has been used to conﬁrm the clinical diagnosis of lym-
phedema.10 In a series of 188 patients, Cambria et al11
used lymphoscintigraphy to measure the transit time to
regional lymph nodes and the appearance of lymph vessels
and nodes to devise a modiﬁed Kleinhans transport index
based on radionuclide distribution pattern. Using this
approach, they accurately differentiated lymphatic causes
of edema from venous and other causes.
NIRFLI uses soluble dye that provides immediate
contrast as it is propelled with lymph, providing a more
rapid, highly resolved, and nonradioactive assessment of
lymphatic anatomy that has been previously demonstrated
to more accurately detect lymphatic abnormalities than
lymphoscintigraphy12 and enables visualization of local
lymphatic transport functionality that cannot be directly
determined by lymphoscintigraphy. Furthermore, by
providing trace administration of ICG in several regions
of the limb, a more comprehensive mapping of the limb-
draining lymphatics can be obtained with a prognostic sig-
niﬁcance for the patient.
In this case, NIRFLI showed no anatomic abnormality
but reduced propulsive lymph pumping on the asymptom-
atic leg compared with normal legs5 and both abnormal
lymphatic anatomy and limited contractile activity on the
symptomatic leg, similar to that seen in patients with
unilateral lymphedema, facilitating the diagnosis of a
lymphatic etiology of her lymphedema. More important,
despite the gross lymphatic anatomy on the subject’s right
leg, the functional lymphatic vessel in the ankle may
portend responsiveness to standard lymphatic treatments
to stimulate the lymphatic pump. NIRFLI deﬁnitively
and rapidly identiﬁed lymphatic anatomic and functional
abnormalities and could, in the future, provide evidence
of lymphatic dysfunction that may need to be addressed
before or simultaneously with hemovascular interventions.
Whereas there is no hemodynamic basis for an outﬂow
stenosis to produce edema in the contralateral limb, it has
been postulated that lymphedema praecox or en tarda is
perhaps an acquired rather than a congenital disorder.
Calnan et al13 theorized that venous obstruction caused
lymphedema praecox and showed abnormal phlebograms
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May-Thurner syndrome and an elevated venous pressure
gradient. Although this patient had many clinical features
of lymphedema praecox, high-grade venous iliac stenosis
in the left leg as a cause of right extremity lymphedema
does not seem to explain her edema, especially because
stenting did not improve swelling. Because NIRFLI was
not conducted before stenting, its effects, if any, on the
lymphatic function in the ipsilateral, treated leg are un-
known. Likewise, because this study was focused only on
characterizing lymphatic contribution, venous imaging
was not conducted at the time of NIRFLI for this subject
previously treated for May-Thurner syndrome.
CONCLUSIONS
Future work using both venous imaging and NIRFLI to
assess changes in venous and lymphatic anatomy and function
after stenting could provide a better understanding of the
interplay between venous outﬂow and lymphatic insufﬁciency
and may improve patient management. Our results suggest
that NIRFLI provides a nonradioactive, “point-of-care”
method to rapidly and economically assess the lymphatic
contribution toedema thatmaybe associatedwith venousdis-
ease. With the availability of NIRFLI, we believe clinical
research opportunities will emerge to better understand the
relative contributions of the lymphatic vasculature in the etiol-
ogy, presentation, and resolution of venous disease.
The authors thank Erik A. Maus, MD, for his clinical
assistance during this study.
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